Author:
Bogdanović Gordana,Jakimov Dimitar,Stojiljkovic Bratislav,Jurišić Vladimir
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference21 articles.
1. Drexler HG. Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes. Leukemia Res 1999;24:109–15
2. Stefan F, Hagop MK. Chronic Leukemias: section 3: myelodisplastic syndromes. In: DeVita T Jr, Hellman S, Rosenberg SA, editors. Cancer: principles & practice of oncology, 7th ed. (electronic version CD). Philadelphia: Lippincott Williams & Wilkins; 2005. Chapter 43: Section 3
3. Lasky J, Sakamoto KM. Topics in pediatric leukemia-myelodisplastic and myeloproliferative disorders of childhood. Medscape General Med 2005;7(1):1–6
4. Delforge M. Understanding the pathogenesis of myelodysplastic syndromes. Hematol J 2003;4:303–9
5. Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P. Promoter hypermethylation of p15 INK4b , HIC1, CDH1, and ER is frequent in myelodyspalstic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol 2006;76:23–32
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献